Harvard researchers have developed an MRI contrast agent that leverages immune cells to detect brain inflammation after mild traumatic brain injury in pigs
Combining rapid DNA sequencing with neural network models to classify brain tumours during surgery helps neurosurgeons decide the extent of tumour resection